Clinicial Trials Directory–
Show: » All Trials | Adult | Pediatric

Ranjana Hira Advani's Trials

Drug Intervention Trials that are Recruiting

Study Title
Investigators
Disease Categories
Safety Study to Evaluate Monoclonal Antibody KW-0761 in Subjects With Peripheral T-Cell Lymphoma
Youn H Kim
Ranjana Hira Advani
Richard T. Hoppe
Sunil Arani Reddy
Natalie Viakhireva
Lymphoma, T-Cell
Lymphoma, T-Cell, Cutaneous
Phase 1 Trial of Oral Ixabepilone
Branimir I Sikic
Ranjana Hira Advani
Dr. A. Dimitrios Colevas
George Albert Fisher M.D. Ph.D.
Charlotte D Jacobs
Pamela Kunz
Heather A. Wakelee
Carcinomas (including Squamous Cell and Adenocarcinoma)
Lenalidomide in Treating Patients With Relapsed Mycosis Fungoides/Sezary Syndrome
Youn H Kim
Ranjana Hira Advani
Richard T. Hoppe
Sunil Arani Reddy
Natalie Viakhireva
Jeff Zwerner
Lymphoma
Lymphoma, Non-Hodgkin
A Pivotal Open-Label Trial of SGN-35 for Hodgkin Lymphoma
Sandra Jeane Horning
Ranjana Hira Advani
Kristen N. Ganjoo
Daniel Aaron Pollyea
Lymphoma, Hodgkin Disease
Hodgkin Disease
A Randomized Phase IIb Placebo-Controlled Study of R-ICE Chemotherapy With and Without SGN-40 for Second-Line Treatment of Patients With DLBCL
Andy Chen
Ranjana Hira Advani
Kristen N. Ganjoo
Sandra Jeane Horning
Lymphoma, Diffuse
Lymphoma, B-Cell
Lymphoma, Non-Hodgkin
Study of Pralatrexate in Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma
Youn H Kim
Ranjana Hira Advani
Richard T. Hoppe
Daniel Navi
Sunil Arani Reddy
Natalie Viakhireva
Anjali Varma Morales
Lymphoma, T-Cell, Cutaneous
A Phase 1 Dose Escalation Study of OMP-21M18 in Subjects With Solid Tumors
Branimir I Sikic
Ranjana Hira Advani
Dr. A. Dimitrios Colevas
Charlotte D Jacobs
Pamela Kunz
Amy Deanne McMullen
Heather A. Wakelee
Carcinomas (including Squamous Cell and Adenocarcinoma)
Safety and Efficacy of RAD001 in Patients With Velcade® Refractory Mantle Cell Lymphoma
Ranjana Hira Advani
Andy Chen MD PhD
Lymphoma, Mantle-Cell
Phase III CHOP + Rituximab vs CHOP + Iodine-131 Monoclonal Anti-B1 Antibody for New Dx Foll NHL
Sandra Jeane Horning
Ranjana Hira Advani
Kristen N. Ganjoo
Michael L Goris
Harlan Pinto
Lymphoma
Phase II Study of Bexxar in Relapsed/Refractory Diffuse Large Cell Lymphoma
Susan J Knox
Ranjana Hira Advani
Kristen N. Ganjoo
Lymphoma, Non-Hodgkin
Lymphoma, Large-Cell, Diffuse
Combination Chemotherapy Plus Low-Dose Radiation Therapy in Treating Patients With Stage I or Stage IIA Hodgkin's Lymphoma
Sandra Jeane Horning
Ranjana Hira Advani
Kristen N. Ganjoo
Richard T. Hoppe
Lymphoma
Lymphoma, Hodgkin Disease
Hodgkin Disease
Genes in Predicting Outcome of Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab and Combination Chemotherapy
Ronald Levy
Ranjana Hira Advani
Lymphoma
Forodesine in the Treatment of Cutaneous T-Cell Lymphoma
Youn H Kim
Ranjana Hira Advani
Richard T. Hoppe
Daniel Navi
Sunil Arani Reddy
Natalie Viakhireva
Lymphoma, T-Cell
Study of Bexxar Combined With External Beam Radiation Therapy for Patients With Relapsed, Bulky Non-Hodgkin's Lymphoma
Susan J Knox
Ranjana Hira Advani
Kristen N. Ganjoo
Michael L Goris
Richard T. Hoppe
Ronald Levy
Lymphoma, Non-Hodgkin
Clinical Trial of PXD101 in Patients With T-Cell Lymphomas
Ranjana Hira Advani
Kristen N. Ganjoo
Sandra Jeane Horning
Youn H Kim
Mark Lee
Lymphoma, T-Cell
Ph I Dose-Escalation of AEG40826-2HCI for Advanced Solid Tumors
Branimir I Sikic
Ranjana Hira Advani
Dr. A. Dimitrios Colevas
George Albert Fisher M.D. Ph.D.
Charlotte D Jacobs
Yelena Krupitskaya
Heather A. Wakelee
Brain Cancer
Cancer
Phase I Dose-Escalation Study of Btk Inhibitor PCI-32765 in Recurrent B Cell Lymphoma
Ranjana Hira Advani
Kristen N. Ganjoo
Daniel Aaron Pollyea
Lymphoma, Non-Hodgkin
Leukemia, Lymphocytic, Chronic
Lymphoma, Small-Cell
Ph II of Single-Agent Enzastaurin for Relapsed Cutaneous T-Cell Lymphoma
Youn H Kim
Ranjana Hira Advani
Richard T. Hoppe
Sunil Arani Reddy
Lymphoma, T-Cell
Ph II, Multicenter, Simon 2-Stage of R788 For Relapsed or Refractory T-Cell Lymphoma
Ranjana Hira Advani
Andy Chen MD PhD
Kristen N. Ganjoo
Sandra Jeane Horning
Ronald Levy
Lymphoma, T-Cell
Photopheresis as an Interventional Therapy for the Treatment of CTCL (Cutaneous T-Cell Lymphoma, Mycosis Fungoides) Stage 1A, 1B, 2A
Youn H Kim
Ranjana Hira Advani
Richard T. Hoppe
Eunice Tsai
Lymphoma, T-Cell, Cutaneous
Study of Pralatrexate and Gemcitabine With Vitamin B12 and Folic Acid in Patients With Relapsed or Refractory Lymphoproliferative Malignancies
Ranjana Hira Advani
Kristen N. Ganjoo
Lymphoma, Hodgkin Disease
Hodgkin Disease
Lymphoma, Non-Hodgkin

Other Trials that are Recruiting

Study Title
Investigators
Disease Categories
Genes in Predicting Outcome of Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab and Combination Chemotherapy
Ronald Levy
Ranjana Hira Advani
Lymphoma
Combination Chemotherapy Plus Low-Dose Radiation Therapy in Treating Patients With Stage I or Stage IIA Hodgkin's Lymphoma
Sandra Jeane Horning
Ranjana Hira Advani
Kristen N. Ganjoo
Richard T. Hoppe
Lymphoma
Lymphoma, Hodgkin Disease
Hodgkin Disease
Ph II of Non-myeloablative Allgnc Trnsplnt Using TLI & ATG In Patients w/ Cutaneous T Cell Lymphoma
Wen-Kai Weng
Ranjana Hira Advani
Sally Arai
Jonathan Benjamin
Richard T. Hoppe
Laura A Johnson
Youn H Kim
Ginna Laport
Robert Lowsky
David Miklos
Robert S Negrin
Judith Anne Shizuru
Sezary Syndrome
Mycoses
Lymphoma, T-Cell, Cutaneous
Phase I/II of a CpG-Activated Whole Cell Vaccine Followed by Autologous “Immunotransplant” for MCL
Ronald Levy
Ranjana Hira Advani
Joshua Brody
Sandra Jeane Horning
Robert S Negrin
Wen-Kai Weng
David Miklos
Lymphoma, Mantle-Cell
Study of Bexxar Combined With External Beam Radiation Therapy for Patients With Relapsed, Bulky Non-Hodgkin's Lymphoma
Susan J Knox
Ranjana Hira Advani
Kristen N. Ganjoo
Michael L Goris
Richard T. Hoppe
Ronald Levy
Lymphoma, Non-Hodgkin
Phase III CHOP + Rituximab vs CHOP + Iodine-131 Monoclonal Anti-B1 Antibody for New Dx Foll NHL
Sandra Jeane Horning
Ranjana Hira Advani
Kristen N. Ganjoo
Michael L Goris
Harlan Pinto
Lymphoma
Lenalidomide in Treating Patients With Relapsed Mycosis Fungoides/Sezary Syndrome
Youn H Kim
Ranjana Hira Advani
Richard T. Hoppe
Sunil Arani Reddy
Natalie Viakhireva
Jeff Zwerner
Lymphoma
Lymphoma, Non-Hodgkin

Trials not Recruiting

Study Title
Investigators
Disease Categories
Safety and Tolerability Study of SNS-314 for Advanced Solid Tumors (Completed)
Ranjana Hira Advani
Andy Chen
Charlotte D Jacobs
Heather A. Wakelee
Carcinomas (including Squamous Cell and Adenocarcinoma)
Rituximab, Combination Chemotherapy, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Stage I or Stage II Lymphoma (No longer recruiting)
Sandra Jeane Horning
Ranjana Hira Advani
Kristen N. Ganjoo
Harlan Pinto
Michael L Goris
Lymphoma
A Single Agent Phase II Study of Romidepsin (Depsipeptide, FK228) in the Treatment of Cutaneous T-Cell Lymphoma (No longer recruiting)
Youn H Kim
Ranjana Hira Advani
Richard T. Hoppe
Natalie Viakhireva
Mycosis Fungoides
Lymphoma, T-Cell, Cutaneous
Cyclosporine in Treating Patients With Recurrent or Refractory Angioimmunoblastic T-Cell Lymphoma (No longer recruiting)
Ranjana Hira Advani
Sandra Jeane Horning
Harlan Pinto
Lymphoma
A Study of ONTAK and CHOP in Newly Diagnosed, Peripheral T-Cell Lymphoma (No longer recruiting)
Ranjana Hira Advani
Kristen N. Ganjoo
Sandra Jeane Horning
Mark Lee
Lymphoma, T-Cell, Peripheral
Rituximab, Combination Chemotherapy, and Bortezomib in Treating Patients With Untreated Mantle Cell Lymphoma (No longer recruiting)
Sandra Jeane Horning
Ranjana Hira Advani
Kristen N. Ganjoo
Harlan Pinto
Lymphoma
Lymphoma, Mantle-Cell
A Dose and Schedule Finding Trial With AMG 531 for CIT in Adults With Lymphoma (Completed)
Ranjana Hira Advani
Kristen N. Ganjoo
Sandra Jeane Horning
Lymphoma
Thrombocytopenia
Lymphoma, Non-Hodgkin
Bevacizumab and Combination Chemotherapy in Treating Patients With Peripheral T-Cell Lymphoma or Natural Killer Cell Neoplasms (No longer recruiting)
Kristen N. Ganjoo
Ranjana Hira Advani
Sandra Jeane Horning
Harlan Pinto
Lymphoma
Study of SGN-40 (Anti-huCD40 mAb) in Patients With Relapsed Diffuse Large B-Cell Lymphoma (No longer recruiting)
Ranjana Hira Advani
Kristen N. Ganjoo
Sandra Jeane Horning
Lymphoma, B-Cell
Rituximab in Treating Patients With Hodgkin's Lymphoma (No longer recruiting)
Sandra Jeane Horning
Ranjana Hira Advani
Richard T. Hoppe
Lymphoma
Rituximab and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Non-Hodgkin's Lymphoma (No longer recruiting)
Ranjana Hira Advani
Sandra Jeane Horning
Kristen N. Ganjoo
Michael L Goris
Harlan Pinto
Lymphoma
An Open Label Six Month Study to Evaluate the Safety and Efficacy of Nitrogen Mustard (NM) 0.04% Ointment Formulation in Patients With Stage I or IIA Mycosis Fungoides (MF) Who Have Completed an Initial 12 Month Treatment With Nitrogen Mustard 0.02% But Without a Complete Response (Enrolling by Invitation)
Youn H Kim
Ranjana Hira Advani
Richard T. Hoppe
Anjali Varma Morales
Sunil Arani Reddy
Natalie Viakhireva
Mycosis Fungoides
Rituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkin's Lymphoma (No longer recruiting)
Sandra Jeane Horning
Ranjana Hira Advani
Harlan Pinto
Kristen N. Ganjoo
Lymphoma

Stanford Medicine Resources:

Footer Links: